We are live on ! Find out more
APLT

Applied Therapeutics
APLT

Delisted

APLT was delisted on the 2nd of February, 2026.

Back to rankings

13 hedge funds and large institutions have $18.1M invested in Applied Therapeutics in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

12.88% more ownership

Funds ownership: 0% → 12.88% (+13%)

Holders
13
Holders Change
+13
Holders Change %
–
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.55M
2
KCM
Knoll Capital Management
Florida
+$4.42M
3
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$4.36M
4
Alkeon Capital Management
Alkeon Capital Management
New York
+$3.79M
5
SI
Sofinnova Investments
California
+$1.34M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$4.83M +$5.55M +586,130 New
KCM
2
Knoll Capital Management
Florida
$3.85M +$4.42M +467,071 New
EMFAT
3
Emerald Mutual Fund Advisers Trust
Pennsylvania
$3.8M +$4.36M +460,980 New
Alkeon Capital Management
4
Alkeon Capital Management
New York
$3.3M +$3.79M +400,000 New
SI
5
Sofinnova Investments
California
$1.17M +$1.34M +142,004 New
Millennium Management
6
Millennium Management
New York
$463K +$532K +56,235 New
BlackRock
7
BlackRock
New York
$228K +$262K +27,704 New
Goldman Sachs
8
Goldman Sachs
New York
$203K +$233K +24,654 New
Bank of New York Mellon
9
Bank of New York Mellon
New York
$172K +$197K +20,818 New
Northern Trust
10
Northern Trust
Illinois
$59K +$67.6K +7,142 New
UBS Group
11
UBS Group
Switzerland
$18K +$20.3K +2,144 New
CCA
12
Catalyst Capital Advisors
New York
$7K +$7.57K +800 New
TRCT
13
Tower Research Capital (TRC)
New York
$4K +$4.68K +494 New

APLT Hedge Fund Activity: Q2 2019 in Review

13 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q2 2019, worth a combined $18.1M.

Buyers outnumbered sellers: 13 funds opened new APLT positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $5.55M.

  • 13 institutional investors held Applied Therapeutics (APLT) as of Q2 2019, up from 0 in Q1 2019.
  • Funds reported $18.1M of Applied Therapeutics stock for Q2 2019.
  • 13 funds opened new Applied Therapeutics positions in Q2 2019 and 0 closed out, a net change of +13 holders.
  • The largest Applied Therapeutics buyer in Q2 2019 was Fidelity Investments, an estimated $5.55M added.

Based on aggregated 13F filings for Q2 2019.